Position in INKT
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$644,609
New position
Shares Held
55,142
first reported quarter
Ownership
1.08%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2
of 27 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 100%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026DNB Asset Management AS holds $309,232,847 across 75 Biotechnology names. INKT ranks #33 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMRN |
Biomarin Pharmaceutical Inc
|
1,268,194 | $72,566,060 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
108,106 | $53,699,493 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
49,314 | $30,749,251 | |
| 4 | INSM |
INSMED Inc
|
213,259 | $22,737,674 | |
| 5 | INCY |
Incyte Corp
|
161,470 | $18,304,239 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
54,076 | $16,278,498 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
65,199 | $15,958,759 | |
| 8 | XENE |
Xenon Pharmaceuticals Inc.
|
200,451 | $12,099,222 |
All Filings in INKT
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $644,609 | 55,142 | Shares | Other | 2026-08-11 | |
| No filing history on record for this holder in this stock. | ||||||